BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• 

  Policy

  China poses increasing security risk as US biotech innovation edge erodes

  The U.S. is scrambling to compete with a strategically positioned China on the biotech stage as the Asian country surpasses America in biomedical research and clinical trials. So far, China is winning.

  August 31, 2026

   · 

  10 min read

   · 

  Michael Gibney
• 

  Neurodegenerative disease

  BMS’ neuro renaissance was built on back of Celgene mega-merger

  Well-known for its oncology efforts and making recent headlines for a rumored mega merger with AstraZeneca, Bristol Myers Squibb is also dedicating considerable resources to neurological and psychiatric diseases, with a “continuum of care” mindset.

  August 31, 2026

   · 

  7 min read

   · 

  Heather McKenzie
• Press Releases

  Leios Therapeutics Announces Exclusive Licensing Agreement and Strategic Investment with Subsidiaries of China Medical System Holdings Ltd. for 10XB-101

  August 31, 2026

   · 

  5 min read
• Press Releases

  Samsung Biologics publishes prospectus for PolyPeptide public tender offer

  August 31, 2026

   · 

  13 min read
• Press Releases

  BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea

  August 31, 2026

   · 

  4 min read
• Press Releases

  AMGEN’S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE

  August 31, 2026

   · 

  24 min read
• Press Releases

  XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation

  August 31, 2026

   · 

  7 min read
• Press Releases

  Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations

  August 31, 2026

   · 

  6 min read
• Press Releases

  Medera Presents Late-Breaking Clinical Trial Data at ESC Congress 2026 Demonstrating Durable Improvement in HFpEF Cardiac Filling Pressures Following SRD-002 Gene Therapy

  August 31, 2026

   · 

  5 min read
• Press Releases

  So-Young Reports Unaudited Second Quarter 2026 Financial Results

  August 31, 2026

   · 

  20 min read